Lanxess rebuilds on its recovery
Article Abstract:
Lanx ess is a speciality chemicals company that was spun-out of Bayer in 2004. Restructuring, cost-saving and portfolio changes have led to the raising of its EBITDA margin from 6.6% to 9.7% and the company has reduced its net debt-EBITDA ratio from 4.5 to less than 1. The other activities of the company which led to its recovery are discussed.
Publication Name: Speciality Chemicals
Subject: Chemicals, plastics and rubber industries
ISSN: 0262-2262
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Akzo's transformational deals are still on course
Article Abstract:
Akzo Nobel is on its way to be a purely coatings and chemicals firm by the end of 2007, with 78.8% of its shareholders approving the acquisition of ICl. The selling of Organon BioSciences for 11 billion euros to Schering-Plough will also be completed by the year's end. The company's finances, facility closures and job cuts are also discussed.
Publication Name: Speciality Chemicals
Subject: Chemicals, plastics and rubber industries
ISSN: 0262-2262
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Lanxess makes its first acquisition as textile disposals are completed. Akzo Nobel sales completed
- Abstracts: In silico prediction of drug solubility: 1: Free energy of hydration. part 2 PECT model analysis and predictions of experimental collisional energy transfer probabilities P(E',E) and moments {delta E} for azulene and biphenylene
- Abstracts: Gas-phase conformations of proteolytically derived protein fragments: influence of solvent on peptide conformation